Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMP | P19971 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.61 |
| ▸ | MAPT | P10636 | 3/20 | 0.61 |
| ▸ | KDM4A | O75164 | 1/20 | 0.60 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | NR3C1 | P04150 | 5/20 | 0.52 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.47 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.47 |
| ▸ | DAO | P14920 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20828256 | 0.79 | TYMP (0.65) | TYMPALDH1A1KDM4ENR3C1NR3C2 | |
| SCHEMBL2672214 | 0.79 | TYMP (1.00) | TYMPALDH1A1MAPTKDM4ENR3C1 | |
| SCHEMBL10857095 | 0.75 | TYMP (0.59) | TYMPALDH1A1KDM4ENR3C1NR3C2 | |
| Diphenylmethane SCHEMBL10711103 | 0.74 | CALM1 (0.63) | TYMPALDH1A1KDM4ENR3C1SMN1; SMN2 | |
| SCHEMBL5197218 | 0.72 | TYMP (0.57) | TYMPALDH1A1MAPTKDM4ENR3C1 | |
| SCHEMBL5313245 | 0.71 | ALDH1A1 (1.00) | ALDH1A1MAPTKDM4EPKMMEN1 | |
| SCHEMBL9353995 | 0.70 | TYMP (0.54) | TYMPALDH1A1MAPTKDM4AKDM4C | |
| SCHEMBL17917621 | 0.70 | HPGD (0.53) | TYMPALDH1A1KDM4ENR3C1SMN1; SMN2 | |
| SCHEMBL12432451 | 0.70 | KDM4E (0.53) | TYMPALDH1A1MAPTKDM4ESMN1; SMN2 | |
| SCHEMBL12611802 | 0.69 | NR3C1 (1.00) | NR3C1NR3C2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1491201-B1 | Methods of reducing toxicity of 5-fluorouracil with acylated pyrimidine nucleosides | WELLSTAT THERAPEUTICS CORP (US) | 2006-03-22 | — | — | EP | claimed |
| EP-0594667-B1 | TREATMENT OF CHEMOTHERAPEUTIC AGENT AND ANTIVIRAL AGENT TOXICITY WITH ACYLATED PYRIMIDINE NUCLEOSIDES | PRO NEURON INC (US) | 2001-09-19 | — | — | EP | claimed |
| EP-0526537-B1 | 5-BENZYL BARBITURATE DERIVATIVES | UNIV BROWN RES FOUND (US) | 1995-07-12 | — | — | EP | claimed |
| US-10031264-B2 | Polarizing plate and display device | FUJIFILM CORPORATION (JP) | 2018-07-24 | — | — | US | disclosed |
| US-9817156-B2 | Polarizing plate protective film, polarizing plate and display device | FUJIFILM CORPORATION (JP) | 2017-11-14 | — | — | US | disclosed |
| US-9817156-B2 | Polarizing plate protective film, polarizing plate and display device | FUJIFILM CORPORATION (JP) | 2017-11-14 | — | — | US | disclosed |
| US-20170322358-A1 | POLARIZING PLATE, FRONT PANEL OF DISPLAY DEVICE, DISPLAY APPARATUS, SUBSTRATE OF TOUCH PANEL, RESISTIVE FILM-TYPE TOUCH PANEL, AND CAPACITANCE-TYPE TOUCH PANEL | FUJIFILM CORPORATION (JP) | 2017-11-09 | — | — | US | disclosed |
| US-20170322358-A1 | POLARIZING PLATE, FRONT PANEL OF DISPLAY DEVICE, DISPLAY APPARATUS, SUBSTRATE OF TOUCH PANEL, RESISTIVE FILM-TYPE TOUCH PANEL, AND CAPACITANCE-TYPE TOUCH PANEL | FUJIFILM CORPORATION (JP) | 2017-11-09 | — | — | US | disclosed |
| US-20170226317-A1 | POLARIZING PLATE PROTECTIVE FILM, POLARIZING PLATE, AND DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2017-08-10 | — | — | US | disclosed |
| US-20170226317-A1 | POLARIZING PLATE PROTECTIVE FILM, POLARIZING PLATE, AND DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2017-08-10 | — | — | US | disclosed |
| US-9678249-B2 | Polarizing plate protective film, polarizing plate and display device | FUJIFILM CORPORATION (JP) | 2017-06-13 | — | — | US | disclosed |
| US-20150253479-A1 | POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY DEVICE INCLUDING THE SAME | FUJIFILM CORPORATION (JP) | 2015-09-10 | — | — | US | disclosed |
| US-20150253479-A1 | POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY DEVICE INCLUDING THE SAME | FUJIFILM CORPORATION (JP) | 2015-09-10 | — | — | US | disclosed |
| US-20140242300-A1 | POLARIZER, POLARIZING PLATE USING THE SAME, LIQUID CRYSTAL DISPLAY DEVICE, AND METHOD OF MANUFACTURING POLARIZING PLATE | FUJIFILM CORPORATION (JP) | 2014-08-28 | — | — | US | disclosed |
| US-20140242300-A1 | POLARIZER, POLARIZING PLATE USING THE SAME, LIQUID CRYSTAL DISPLAY DEVICE, AND METHOD OF MANUFACTURING POLARIZING PLATE | FUJIFILM CORPORATION (JP) | 2014-08-28 | — | — | US | disclosed |
| US-20140242302-A1 | LAMINATE, POLARIZING PLATE, LIQUID CRYSTAL DISPLAY DEVICE, AND METHOD OF MANUFACTURING POLARIZING PLATE | FUJIFILM CORPORATION (JP) | 2014-08-28 | — | — | US | disclosed |
| US-20140242302-A1 | LAMINATE, POLARIZING PLATE, LIQUID CRYSTAL DISPLAY DEVICE, AND METHOD OF MANUFACTURING POLARIZING PLATE | FUJIFILM CORPORATION (JP) | 2014-08-28 | — | — | US | disclosed |
| EP-1365755-B1 | USE OF PYRIMIDINE NUCLEOSIDES AND/OR THE PRODRUGS THEREOF FOR COMBATING THE SIDE-EFFECTS OF HAART (HIGHLY ACTIVE ANTI-RETROVIRAL THERAPY) AND OTHER ANTI-VIRAL THERAPIES | PHARMA NORD APS (DK) | 2008-10-22 | — | — | EP | disclosed |
| EP-1365755-A2 | USE OF PYRIMIDINE NUCLEOSIDES AND/OR THE PRODRUGS THEREOF FOR COMBATING THE SIDE-EFFECTS OF HAART (HIGHLY ACTIVE ANTI-RETROVIRAL THERAPY) AND OTHER ANTI-VIRAL THERAPIES | Walker, Ulrich (DE) | 2003-12-03 | — | — | EP | disclosed |
| WO-2002069943-A2 | USE OF PYRIMIDINE NUCLEOSIDES AND/OR THE PRODRUGS THEREOF FOR COMBATING THE SIDE-EFFECTS OF HAART (HIGHLY ACTIVE ANTI-RETROVIRAL THERAPY) AND OTHER ANTI-VIRAL THERAPIES | WALKER ULRICH (DE) | 2002-09-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170226317-A1 | POLARIZING PLATE PROTECTIVE FILM, POLARIZING PLATE, AND DISPLAY DEVICE | NBAS, SSB, BIRC5 | TYMP 4847/4885ALDH1A1 4014/4885MAPT 4098/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.